Cargando…

Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda

INTRODUCTION: WHO recommends vaccination against HPV for girls before sexual debut. Uganda started HPV vaccination in 2008 as pilot programs in 2 districts, followed by national roll out in 2015. Despite the availability of vaccines against human papillomavirus (HPV) in Uganda in the period covered...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrick, Lydia, Bakeera-Kitaka, Sabrina, Rujumba, Joseph, Malande, Oliver Ombeva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182299/
https://www.ncbi.nlm.nih.gov/pubmed/35679304
http://dx.doi.org/10.1371/journal.pone.0269655
_version_ 1784724001350746112
author Patrick, Lydia
Bakeera-Kitaka, Sabrina
Rujumba, Joseph
Malande, Oliver Ombeva
author_facet Patrick, Lydia
Bakeera-Kitaka, Sabrina
Rujumba, Joseph
Malande, Oliver Ombeva
author_sort Patrick, Lydia
collection PubMed
description INTRODUCTION: WHO recommends vaccination against HPV for girls before sexual debut. Uganda started HPV vaccination in 2008 as pilot programs in 2 districts, followed by national roll out in 2015. Despite the availability of vaccines against human papillomavirus (HPV) in Uganda in the period covered by the study, there was reported low HPV vaccine uptake and completion especially of the second dose in Uganda; with little information available on timely completion of HPV vaccine and the associated factors in Uganda. This study was therefore done to determine the HPV vaccine dose 2 completion and describe the possible factors associated with timely HPV vaccine completion and non-completion among girls of age 9–14 years attending the adolescent clinic at Mulago hospital. METHODS: A retrospective mixed methods study was conducted in Mulago National Referral hospital adolescent clinic. Data were mainly collected through review of charts and folders for clinic attendance by eligible girls and focus group discussions with eligible girls that completed the 2 doses of HPV vaccine on recommended/scheduled time. RESULTS: Out of the 201 girls studied, 87 girls (43.3%) had timely completion of the HPV vaccination. Knowledge about HPV infection and HPV vaccine benefits, positive peer influence and healthcare worker recommendation to get vaccinated at health facility level positively influenced timely completion of HPV vaccine. Among barriers to completion of HPV vaccine identified were: inadequate information about HPV infection and HPV vaccine, concerns about HPV vaccine efficacy and safety, unclear communication with adolescents/caregivers from healthcare workers and -stock out of the HPV vaccine. CONCLUSION: Timely completion of the second dose of HPV vaccine among girls attending the adolescent clinic of Mulago hospital was low (at 43.3%) but higher when compared to earlier published reports. Interventions around improved social mobilization, enhanced outreach and static vaccination approach and education of eligible girls on HPV vaccination can help increase vaccine uptake.
format Online
Article
Text
id pubmed-9182299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-91822992022-06-10 Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda Patrick, Lydia Bakeera-Kitaka, Sabrina Rujumba, Joseph Malande, Oliver Ombeva PLoS One Research Article INTRODUCTION: WHO recommends vaccination against HPV for girls before sexual debut. Uganda started HPV vaccination in 2008 as pilot programs in 2 districts, followed by national roll out in 2015. Despite the availability of vaccines against human papillomavirus (HPV) in Uganda in the period covered by the study, there was reported low HPV vaccine uptake and completion especially of the second dose in Uganda; with little information available on timely completion of HPV vaccine and the associated factors in Uganda. This study was therefore done to determine the HPV vaccine dose 2 completion and describe the possible factors associated with timely HPV vaccine completion and non-completion among girls of age 9–14 years attending the adolescent clinic at Mulago hospital. METHODS: A retrospective mixed methods study was conducted in Mulago National Referral hospital adolescent clinic. Data were mainly collected through review of charts and folders for clinic attendance by eligible girls and focus group discussions with eligible girls that completed the 2 doses of HPV vaccine on recommended/scheduled time. RESULTS: Out of the 201 girls studied, 87 girls (43.3%) had timely completion of the HPV vaccination. Knowledge about HPV infection and HPV vaccine benefits, positive peer influence and healthcare worker recommendation to get vaccinated at health facility level positively influenced timely completion of HPV vaccine. Among barriers to completion of HPV vaccine identified were: inadequate information about HPV infection and HPV vaccine, concerns about HPV vaccine efficacy and safety, unclear communication with adolescents/caregivers from healthcare workers and -stock out of the HPV vaccine. CONCLUSION: Timely completion of the second dose of HPV vaccine among girls attending the adolescent clinic of Mulago hospital was low (at 43.3%) but higher when compared to earlier published reports. Interventions around improved social mobilization, enhanced outreach and static vaccination approach and education of eligible girls on HPV vaccination can help increase vaccine uptake. Public Library of Science 2022-06-09 /pmc/articles/PMC9182299/ /pubmed/35679304 http://dx.doi.org/10.1371/journal.pone.0269655 Text en © 2022 Patrick et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Patrick, Lydia
Bakeera-Kitaka, Sabrina
Rujumba, Joseph
Malande, Oliver Ombeva
Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda
title Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda
title_full Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda
title_fullStr Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda
title_full_unstemmed Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda
title_short Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda
title_sort encouraging improvement in hpv vaccination coverage among adolescent girls in kampala, uganda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182299/
https://www.ncbi.nlm.nih.gov/pubmed/35679304
http://dx.doi.org/10.1371/journal.pone.0269655
work_keys_str_mv AT patricklydia encouragingimprovementinhpvvaccinationcoverageamongadolescentgirlsinkampalauganda
AT bakeerakitakasabrina encouragingimprovementinhpvvaccinationcoverageamongadolescentgirlsinkampalauganda
AT rujumbajoseph encouragingimprovementinhpvvaccinationcoverageamongadolescentgirlsinkampalauganda
AT malandeoliverombeva encouragingimprovementinhpvvaccinationcoverageamongadolescentgirlsinkampalauganda